Edwards Lifesciences (EW) Competitors $75.31 -0.18 (-0.24%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$75.57 +0.26 (+0.34%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EW vs. BSX, SYK, MDT, BDX, IDXX, RMD, DXCM, STE, PODD, and BAXShould you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "health care equipment" industry. Edwards Lifesciences vs. Boston Scientific Stryker Medtronic Becton, Dickinson and Company IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, community ranking, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment. Does the media refer more to BSX or EW? In the previous week, Boston Scientific had 3 more articles in the media than Edwards Lifesciences. MarketBeat recorded 39 mentions for Boston Scientific and 36 mentions for Edwards Lifesciences. Boston Scientific's average media sentiment score of 1.05 beat Edwards Lifesciences' score of 0.95 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 23 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 18 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is BSX or EW more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Boston Scientific's net margin of 11.07%. Edwards Lifesciences' return on equity of 19.40% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Boston Scientific11.07% 17.80% 9.85% Edwards Lifesciences 72.93%19.40%14.37% Do analysts rate BSX or EW? Boston Scientific currently has a consensus target price of $114.52, suggesting a potential upside of 11.01%. Edwards Lifesciences has a consensus target price of $79.45, suggesting a potential upside of 5.50%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 0 Sell rating(s) 0 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 3.04Edwards Lifesciences 1 Sell rating(s) 12 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has stronger earnings & valuation, BSX or EW? Edwards Lifesciences has lower revenue, but higher earnings than Boston Scientific. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBoston Scientific$17.55B8.69$1.85B$1.3775.30Edwards Lifesciences$5.25B8.43$4.17B$7.0010.76 Do insiders and institutionals have more ownership in BSX or EW? 89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer BSX or EW? Edwards Lifesciences received 272 more outperform votes than Boston Scientific when rated by MarketBeat users. Likewise, 70.76% of users gave Edwards Lifesciences an outperform vote while only 69.90% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformBoston ScientificOutperform Votes106669.90% Underperform Votes45930.10% Edwards LifesciencesOutperform Votes133870.76% Underperform Votes55329.24% Which has more risk and volatility, BSX or EW? Boston Scientific has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. SummaryBoston Scientific beats Edwards Lifesciences on 10 of the 19 factors compared between the two stocks. Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EW vs. The Competition Export to ExcelMetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$44.27B$9.16B$5.53B$18.96BDividend YieldN/A1.64%5.11%4.01%P/E Ratio10.8119.1622.5932.87Price / Sales8.4369.14401.3528.03Price / Cash27.0419.6738.1817.52Price / Book6.805.016.774.47Net Income$4.17B$284.66M$3.22B$1.02B7 Day Performance-0.98%-0.34%1.39%0.59%1 Month Performance4.47%2.93%2.78%-3.54%1 Year Performance-11.46%-17.64%15.85%3.80% Edwards Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWEdwards Lifesciences4.6129 of 5 stars$75.31-0.2%$79.45+5.5%-10.6%$44.27B$5.25B10.8117,300Short Interest ↓BSXBoston Scientific4.5267 of 5 stars$102.17+0.3%$114.52+12.1%+42.9%$151.12B$17.55B81.7445,000Analyst UpgradePositive NewsSYKStryker4.8203 of 5 stars$366.58+0.4%$423.53+15.5%+14.1%$139.92B$22.60B47.2451,000Earnings ReportPositive NewsMDTMedtronic4.5496 of 5 stars$83.98-0.2%$96.14+14.5%+3.1%$107.71B$33.20B25.5395,000Positive NewsBDXBecton, Dickinson and Company4.9709 of 5 stars$205.10+0.0%$272.86+33.0%-27.5%$58.89B$20.64B34.0777,000Earnings ReportDividend AnnouncementAnalyst DowngradeNews CoverageGap DownIDXXIDEXX Laboratories4.0405 of 5 stars$433.99-0.8%$523.75+20.7%+0.7%$35.17B$3.90B40.6710,800Earnings ReportNews CoveragePositive NewsGap UpRMDResMed4.0455 of 5 stars$234.06-0.8%$258.83+10.6%+9.9%$34.38B$5.02B27.638,160Analyst UpgradePositive NewsDXCMDexCom4.912 of 5 stars$71.18-0.7%$99.00+39.1%-44.2%$27.91B$4.03B49.787,600Earnings ReportNews CoveragePositive NewsSTESTERIS4.5026 of 5 stars$225.26+0.1%$258.75+14.9%+8.4%$22.13B$5.40B47.8316,000Upcoming EarningsShort Interest ↑Positive NewsPODDInsulet4.4844 of 5 stars$259.52-0.5%$292.06+12.5%+47.0%$18.23B$2.07B44.822,600Upcoming EarningsAnalyst DowngradeBAXBaxter International4.7386 of 5 stars$30.60+1.3%$38.56+26.0%-24.1%$15.70B$10.64B-23.9160,000Earnings ReportNews CoverageGap Up Related Companies and Tools Related Companies Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EW) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
